Takeda Pharma’s Iclusig Poised for Priority Review by CDE for Leukemia Treatments
The Center for Drug Evaluation (CDE) website has indicated that Takeda Pharma’s (TYO: 4502) Iclusig...
Company
Arctic Vision Partners with Sinopharm Group for Ophthalmic Product Distribution in China
China-based ophthalmology specialist Arctic Vision has entered into a strategic partnership with Sinopharm Group Distribution...
Bioyond Robotics Secures $29 Million in Series A and A+ Financing Rounds
Bioyond Robotics, a Shanghai-based intelligent automation company, has reportedly raised around RMB 200 million (USD...
Jiangsu Hillgene Biopharma Secures Tens of Millions in Series A Financing for Cell Therapy R&D
China-based cell therapy-focused Contract Development and Manufacturing Organization (CDMO) Jiangsu Hillgene Biopharma Co., Ltd has...
Forecyte Bio Expands with New Cell and Gene Therapy GMP Facility in Shanghai
Maryland-based Contract Development and Manufacturing Organization (CDMO) Forecyte Biotechnologies has announced the opening of a...
Yiling Pharmaceutical’s XY0206 Advances to Phase III Trial for FLT3-ITD AML
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced its plans to initiate a Phase...
Jiangsu Yuyue Medical Secures NMPA Approval for Semi-Automatic External Defibrillator
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE: 002223), a China-based medical device company,...
MicuRx Pharmaceuticals Initiates Phase III Study for MRX-4 in Diabetic Foot Infection Treatment
Sino-US firm MicuRx Pharmaceuticals Inc. has announced the initiation of a Phase III clinical study...
AstraZeneca Partners with Guangzhou Institute to Advance Respiratory Medicine Research
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced a partnership with China’s Guangzhou Institute...
Indonesia and China Deepen Healthcare Ties with High-Level Dialogue and New Agreements
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
TYK Medicines Secures FDA Approval for Next-Generation TKI Clinical Trial
China-based TYK Medicines, Inc. has announced that it has received clinical trial approval from the...
Sequanta Technologies Partners with Element Biosciences to Expand Single-Cell Applications
Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic...
Yifan Pharmaceutical Receives NMPA Approval for Hyruan ONE in Knee Osteoarthritis Treatment
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) has announced receiving market approval from the National...
Junshi Biosciences Challenges Alynlam’s PCSK9 siRNA Patent with CNIPA
Junshi Biosciences (SHA: 688180) is reportedly taking steps to challenge a key patent held by...
ApolloBio Partners with Baidu Health to Enhance Marketing of IgM Nano Immunoglobulin Spray
Guangzhou-based biotech ApolloBio has signed a strategic cooperation agreement with Baidu Health. Under this partnership,...
Yantai Dongcheng Pharmaceutical Gets Singapore Regulatory Approval for 177Lu-LNC1004 Phase I Study
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving the green light...
AcoStream Second-Generation Receives NMPA Marketing Approval for Peripheral Vascular Use
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
Shenzhen Kangtai Biological Partners with Biotis for 13-Valent Pneumococcal Vaccine in Indonesia
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has struck a partnership with Indonesian...
Harbour BioMed and AstraZeneca Partner to Advance Pharmaceutical Innovation in Yangtze River Delta
Harbour BioMed (HKG: 2142), a biotech with operations in the United States, the Netherlands, and...
Shuwen Biotech’s Subsidiary Signs Promotion Agreement with Sysmex Europe for Breast Cancer Detection Product
China-based diagnostic specialist Shuwen Biotech Co., Ltd announced that its wholly-owned German subsidiary, Cerca Biotech...